Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-A

Endocrinology

Volumn 145, Issue 2, 2004, Pages 951-958

  Li, Yuhao ^a   Kishimoto, Ichiro ^a   Saito, Yoshihiko ^a,d   Harada, Masaki ^a   Kuwahara, Koichiro ^a   Izumi, Takehiko ^a   Hamanaka, Ichiro ^a   Takahashi, Nobuki ^a   Kawakami, Rika ^a   Tanimoto, Keiji ^a   Nakagawa, Yasuaki ^a   Nakanishi, Michio ^a   Adachi, Yuichiro ^a   Garbers, David L ^b   Fukamizu, Akiyoshi ^c   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE; FLUTAMIDE; GUANYLATE CYCLASE; MESSENGER RNA; RECEPTOR BLOCKING AGENT; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CASTRATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC CORRELATION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; SEX DIFFERENCE; SPECIES DIFFERENCE; WILD TYPE;

ANDROGENS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; FEMALE; FIBROSIS; FLUTAMIDE; GENE DELETION; GENE EXPRESSION PROFILING; GUANYLATE CYCLASE; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; ORCHIECTOMY; OVARIECTOMY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANDROGEN; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 10744223054     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0816     Document Type: Article

References (50)

1. Devereux RB, Pickering TG, Alderman MH, Chien S, Borer JS, Laragh JH 1987 Left ventricular hypertrophy in hypertension: prevalence and relationship to pathophysiologic variables. Hypertension 9(Suppl II):53-60
2. Kaplinsky E 1994 Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality. Cardiovasc Drugs Ther 8:549-556
3. Neyses L, Pelzer T 1995 The biological cascade leading to cardiac hypertrophy. Eur Heart J 16(Suppl N):8-11
4. Weber KT, Brilla CG 1991 Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849-1865
5. Hayward CS, Kelly RP, Collins P 2000 The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46: 28-49
6. Fiebach NH, Viscoli CM, Horwitz RI 1990 Differences between women and men in survival after myocardial infarction. JAMA 263:1092-1096
7. de Simone G, Devereux RB, Daniels SR, Meyer RA 1995 Gender differences in ventricular growth. Hypertension 26:979-983
8. Luchner A, Brockel U, Muscholl M, Hense HW, Doring A, Riegger GA, Schunkert H 2002 Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 53:720-727
9. Crabbe DL, Dipla K, Ambati S, Zafeiridis A, Gaughan JP, Houser SR, Margulies KB 2003 Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 41:300-306
10. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH 1999 Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264-273
11. Meyer R, Linz KW, Surges R, Meinardus S, Vees J, Hoffmann A, Windholz O, Grohe C 1998 Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol 83:305-321
12. Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ 1998 Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256-261
13. Dubey RK, Gillespie DC, Jackson EK, Keller PJ 1998 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31:522-528
14. Chen SJ, Li H, Durand J, Oparil S, Chen YF 1996 estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 93:577-584
15. Somjen D, Kohen F, Jaffe A, Amir-Zaltsman Y, Knoll E, Stern N 1998 Effect of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 32:39-45
16. Fujimoto R, Morimoto I, Morita E, Sugimoto H, Ito Y, Eto S 1994 Androgen receptors, 5α-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J Steroid Biochem Mol Biol 50:169-174
17. Cabral AM, Vasquez EC, Moyses MR, Antonio A 1988 Sex hormone modulation of ventricular hypertrophy in sinoaortic denervated rats. Hypertension 11:193-197
18. Malhotra A, Buttrick P, Scheuer J 1990 Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol 259:H866-H871
19. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A 1995 Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65-68
20. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N 1997 Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94:14731-14735
21. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, Murakami K 1995 Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270:18719-18722
22. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Takahashi N, Kawakami R, Tanimoto K, Nakagawa Y, Nakanishi M, Adachi Y, Garbers DL, Fukamizu A, Nakao K 2002 Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Circulation 106:1722-1728
23. Labrie F 1993 Mechanisms of action and pure antiandrogenic properties of flutamide. Cancer 72:3816-3827
24. Reckelhoff JF, Zhang H, Srivastava K, Granger JP 1999 Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34:920-923
25. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
26. van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA 2001 17β-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419-1423
27. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HHS 1975 Potential value of plants as sources of new antifertility agents. J Pharm Sci 64:717-754
28. Price KR, Fenwick GR 1985 Naturally occurring oestrogens in foods: a review. Food Addit Contam 2:73-106
29. Degen GH, Janning P, Diel P, Bolt HM 2002 Estrogenic isoflavones in rodent diets. Toxicol Lett 128:145-157
30. Mcgill HC, Sheridan PJ 1981 Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ Res 48:238-244
31. Sadoshima J, Izumo S 1993 Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of AT1 receptor subtype. Circ Res 73:413-423
32. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM 1993 Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res 72: 1245-1254
33. McDonald KM, Garr M, Carlyle PF, Francis GS, Hauer K, Hunter DW, Parish T, Stillman A, Cohn JN 1999 Relative effects of α1-adrenergic blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation 90:3034-3046
34. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D 2001 Tissue rennin-angiotensin systems: new insights from experimental animal models in hypertensive research. J Mol Med 79:76-102
35. Pratt RE 1999 Angiotensin II and the control of cardiovascular structure. J Am Soc Nephrol 10:5120-5128
36. Weber KT 1997 Extra cellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation 96:4065-4082
37. Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM 2000 Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 106:589-597
38. Vikstrom KL, Factor SM, Leinwand LA 1996 Mice expressing mutant myosin are a model for hypertrophic cardiomyopathy. Mol Med 2:556-567
39. Wallen WJ, Cserti C, Belanger MP, Wittnich C 2000 Gender-differences in myocardial adaptation to afterload in normotensive and hypertensive rats. Hypertension 36:774-779
40. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB 1992 Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86:1099-1107
41. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH 1998 Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 32:1118-1125
42. Villarreal FJ, Dillmann WH 1992 Cardiac hypertrophy-induced changes in mRNA levels for TGF-β1, fibronectin, and collagen. Am J Physiol Heart Circ Physiol 262:H1861-H1866
43. Chen YF, Naftilan AJ, Oparil S 1992 Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19:456-463
44. Freshour JR, Chase SE, Vikstrom KL 2002 Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am J Physiol Heart Circ Physiol 283:H1997-H2003
45. Border WA, Nobel NA 1994 Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292
46. Kagami S, Border WA, Miller DE, Noble NA 1994 Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437
47. Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA 1989 Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Am J Med 87:24S-28S
48. Sadoshima J, Izumo S 1997 The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59:551-571
49. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K 2000 Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 86:841-845
50. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M 1993 Possibility of down-regulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 88:811-813